MENU

DNTH Dianthus Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
DNTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
DNTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

DNTH is expected to report earnings to fall 19.58% to -303 cents per share on September 18

Dianthus Therapeutics DNTH Stock Earnings Reports
Q2'23
Est.
$-3.04
Q3'23
Missed
by $3.22
Q1'23
Missed
by $0.07
Q4'22
Missed
by $0.02
Q3'22
Beat
by $0.02
The last earnings report on November 09 showed earnings per share of -377 cents, missing the estimate of -56 cents. With 103.21K shares outstanding, the current market capitalization sits at 824.43M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7 Times Square
Phone
+1 929 999-4055
Employees
53
Web
https://www.dianthustx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OSCNX21.690.17
+0.79%
Invesco Main Street Small Cap R
GGESX23.52N/A
N/A
Nationwide Global Sust Eq Instl Svc
VLPCX14.27N/A
N/A
Virtus Duff & Phelps Sel MLP & Engy C
TRZRX14.64-0.03
-0.20%
T. Rowe Price Real Assets Z
AMTAX9.01-0.03
-0.33%
AB All Market Real Return A

DNTH and Stocks

Correlation & Price change

A.I.dvisor tells us that DNTH and XTLB have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DNTH and XTLB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+0.93%
XTLB - DNTH
25%
Poorly correlated
-3.49%
TPST - DNTH
23%
Poorly correlated
-1.71%
CRNX - DNTH
22%
Poorly correlated
-0.13%
AVTX - DNTH
21%
Poorly correlated
-0.68%
FTRE - DNTH
13%
Poorly correlated
+2.62%
More